Datum der Indexierung 04.10.2024 23:31:04
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Hemophilia B Corporate Message 15 Jan 2024 Story Bern, Switzerland – 15 January 2024 – Global biotechnology leader CSL (ASX: CSL) announced today that Swissmedic has authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene rategic goals. Read About R&D Patients Patients Community Engagement Find Your Disease Find Your Disease Immunodeficiency and Autoimmune Diseases Hereditary Bleeding Disorders Hereditary Angioedema Enzyme Deficiency We are proud t
Text Inhalt Text aus URL
Log Metriken 86111